Fact CheckerSign in

NCT03694145Active, not recruiting

Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

The objective of this study is to compare the results of a deep learning approach to diabetic retinopathy assessment with results from (1) an in-person examination with an ophthalmologist, and (2) the assessments of optometrists involved in a teleretinal screening program.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
300 (actual)
First submitted
1 Oct 2018
Start date
25 Oct 2018
Primary completion date
31 May 2027
Lead sponsor
Charles Drew University of Medicine and Science
NCT number
NCT03694145

What you commit to

  • Study type: Observational
  • Participants enrolled: 300
  • From 25 Oct 2018 to the primary completion date, 31 May 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have previously been seen in the current year by LACDHS's Teleretinal Diabetic Retinopathy Screening Program and Reading Center
  • Previously eligible patients who do not return for an in-person eye exam within 3 months of receiving a teleretinal screening (In order for the results of the teleretinal screening and in-person eye examinations to yield similar information, patients who do not return for their in-person eye exam within 3 months of their teleretinal screening will not be able to remain in the study. This is because significant eye changes not documented by the teleretinal screening may occur after a 3-month period).

Other illness

  • Patients with gestational diabetes

Age

  • Patients under the age of 18 years

Other

  • Patients whose teleretinal screening exam images do not yield readable results, as gradable images are needed for later comparison against ophthalmologist reads.

Who the study is looking for

  • Patients diagnosed with Type I or Type II Diabetes
  • Patients who are over the age of 18 years
  • Patients who have not previously been seen in the current year by the LACDHS Teleretinal Diabetic Retinopathy Screening Program and Reading Center
  • Patients whose teleretinal screening exam images yield readable results

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Los Angeles Department of Public Health
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Charles R. Drew University of Medicine and Science
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.